Brazil moves to stay abreast of dengue diagnostics developments
This article was originally published in Clinica
The Brazilian health ministry is putting the dissemination of information on diagnostics advances at the top of its agenda for tackling dengue, despite a huge fall in the number of cases so far this year. "From an epidemiological vigilance point of view, laboratories must be kept abreast of the latest diagnostic techniques," said the health ministry of one of the main reasons for hosting the International Course on Dengue Control and Prevention Management, held in Fortaleza, on August 15-26.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.